Abstract
The extraordinarily high incidence of cancers of many different varieties--carcinomas and lymphomas--in organ-transplant patients being maintained for long periods of time with immunosuppressive drugs is briefly reviewed. The role of immunosurveillance as a primary defense mechanism against cancer in human beings is consistent with these observations and is in need of further investigation. Conceivably, this mechanism may play a somewhat different role in humans from what has been observed in most experimental animal models.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cahan W. G. Multiple primary cancers of the lung, esophagus, and other sites. Cancer. 1977 Oct;40(4 Suppl):1954–1960. doi: 10.1002/1097-0142(197710)40:4+<1954::aid-cncr2820400830>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
- Greenberg A. H., Greene M. Non-adaptive rejection of small tumour inocula as a model of immune surveillance. Nature. 1976 Nov 25;264(5584):356–359. doi: 10.1038/264356a0. [DOI] [PubMed] [Google Scholar]
- Klein E., Holtermann O. A., Helm F., Rosner D., Milgrom H., Adler S., Stoll H. L., Jr, Case R. W., Prior R. L., Murphy G. P. Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program. Transplant Proc. 1975 Jun;7(2):297–315. [PubMed] [Google Scholar]
- Krikorian J. G., Anderson J. L., Bieber C. P., Penn I., Stinson E. B. Malignant neoplasms following cardiac transplantation. JAMA. 1978 Aug 18;240(7):639–643. [PubMed] [Google Scholar]
- Morris P. J. Cyclosporin A. Transplantation. 1981 Nov;32(5):349–354. [PubMed] [Google Scholar]
- North R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med. 1982 Apr 1;155(4):1063–1074. doi: 10.1084/jem.155.4.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977 Mar;9(1):1121–1127. [PubMed] [Google Scholar]
- Sheil A. G., Mahony J. F., Horvath J. S., Johnson J. R., Tiller D. J., Stewart J. H., May J. Cancer following successful cadaveric donor renal transplantation. Transplant Proc. 1981 Mar;13(1 Pt 2):733–735. [PubMed] [Google Scholar]
- Spees E. K., Jr, Kramer K. K., Light J. A., Oakes D. D., Zimmerman L. E. Reactivation of ocular malignant melanoma after renal transplantation. Transplantation. 1980 May;29(5):421–424. doi: 10.1097/00007890-198005000-00017. [DOI] [PubMed] [Google Scholar]
- Zisbrod Z., Haimov M., Schanzer H., Ambinder E., Burrows L. Kaposi's sarcoma after kidney transplantation. Report of complete remission of cutaneous and visceral involvement. Transplantation. 1980 Nov;30(5):383–384. doi: 10.1097/00007890-198011000-00016. [DOI] [PubMed] [Google Scholar]